Allegro DVT Supports AV2 Standard Ecosystem with the Launch of Comprehensive Compliance Test Tools
25.9.2025 15:30:00 EEST | Business Wire | Press release
AllegroDVT, a leading provider of Digital Video Technology Solutions, today announced the release of a complete range of Solutions to accelerate the adoption of the next-generation AV2 codec from the Alliance for Open Media (AOMedia).
The AV2 Codec, set for 2025 year-end release as announced by AOMedia on September 15th, represents a major technological leap in video compression performance. It will notably provide enhanced support for AR/VR applications, better handling of screen content and many other improvements for superior media experiences.
AV2 products announced by AllegroDVT include:
- Sirius AV2 Compliance Test Suite – A comprehensive Decoder Verification Solution designed to ease ultimate AV2 conformance based on the publicly available AVM source code. Sirius AV2 Test Suite enables a robust validation of Hardware and Software based AV2 Decoders by providing test cases covering all corner cases, equations, and branch conditions. A full coverage report is also included to give developers complete confidence in their AV2 decoder implementation to meet the highest compliance standards required for market readiness
- Astralis AV2 VQ Analyzer – A powerful analysis and debugging tool that provides deep insights into AV2 bitstreams. It helps developers optimize efficiency, accelerates debugging, to deliver higher quality and conformant Video Encoder & Decoders in shorter time-to-market
- Pulsar AV2 Decoder Semiconductor IP – Ready-to-integrate Semiconductor IP that brings best-in-class AV2 decoding performance to SoCs powering next generation Consumer devices and streaming platforms while enabling energy-efficient, high-quality playback. Pulsar AV2 Decoder IP will be available shortly after the AV2 specification release
"By combining compliance bitstreams, advanced analysis tools, and semiconductor IPs for the upcoming AV2 codec, AllegroDVT is uniquely positioned to help the video industry foster adoption of AV2 by accelerating the release of AV2 products" said Nouar Hamze, CEO of AllegroDVT. “With over 22 years’ experience, in providing Video Compliance Solutions and successful track record of delivering high quality AV1, VP9, VVC, HEVC, AVC and LCEVC solutions, AllegroDVT shows once again its commitment to supporting open video standards and providing tools and technologies necessary for seamless industry adoption.”
About Allegro DVT
AllegroDVT, a worldwide company headquartered in Grenoble/France, is a leading provider of digital video technology solutions including video compliance tools and semiconductor video IPs. With the acquisition of Vicuesoft, AllegroDVT expanded its video compliance tools portfolio adding the industry leading VQ Analyzer software.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250925020294/en/
Contacts
Press: marcom@allegrodvt.com / +33-04-76-42-66-85
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release
Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release
Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom